drome. Extremes may reflect pathophysiologic mechanisms in these conditions. Mean "normal" values served to assess nucleotide response (or lack of it) to glucagon or PTH in diseases such as glycogenoses or pseudohypoparathyroidism.
CYCLIC AMP AND Factors controlling uteroplacental blood flow are vaguely unerstood,but estrogen appears of importance. Systemic infusions0 into pregnant ewes result in increases in maternal estrone(E1) stradiol(EZ),and uterine blood flow. Although D is a substrate or ovine estrogen production during pregnancy,tlie conversionsit nd fetal role are unknown. To investigate this 10 pregnant ewes 24-150 days of gestation,were re pared with catheters in fetal mbilical vein(y),femoral artery(a),and vena cava(fv),and matera1 uterine vein(v) ,femoral artery (A) ,and vena cava(~) ,permittin! imultaneous arteriovenous(a-v)sampling from fetal and maternal lacental circulations. Uterine artery flow probes were placed il ewes. After the 4th postop day simultaneous samples taken from ,v,a and y prior to and 7. 5,15,30,60,90,120,150 and 180 min. af er the infusion of 6mg D into fv. Uterine blood flow rose 22 + %*(Mean + SE) at 110 min. At 7.5 min. AEl(pg/ml)was:A=281*,v= 53*,a=621*,y=715*;AE2(pg/ml):A=51.6*,~=89.8*,a=307*,y=295*;and ehydroisoandrosterone sulfate(DS,ng/ml):A=66.9*,v=125*,a=1040*, 730*. In 3 fetuses D was measured in a and y at 0 and 15 min.; I g/ml=73.6 and 4.94,respectively. All values returned toward con rol levels after 180 min. The results of these studies are conistent with conversion of exogenous D by the fetal-placental nit to DS,E1 and E2. Although estrogen levels seen at the onset f parturition were achieved,parturition was not induced bv D. oreover,fetal-placentalaromatase activity does not appear to be ate limiting in ovine estrogen production. *p < 0.05
Developmental Medicine, Vancouver. In umbilical cord and maternal blood plasma free carnitine is si&mificantly lower than in plasma of non-pregnant women. Acetylcarnitine but not free carnitine was elevated in cord blood from premature in comparison with full-term infants. In the first hours after birth plasma acetylcarnitine increases significantly but free carnitine remains unchanged. However, ir infants receiving carnitine free diets (soy protein based formul the levels of both free and acetylcarnitine are significantly lower than in infants receiving human breast milk or cow's milk based formulas which contain 50-200 nmolfml carnitine. There was no correlation between the dietary intake of the amino acid precursors of carnitine, methionine and leucine, and carnitine blood levels. Soy formulas contain more methionine and leucine than cow's milk formulas and human breast milk; hence decreased carnitine in infants fed soy formula is not due to decreased synthesis because of a lack of precursor amino acids.
Carnitine functions to facilitate transport of fatty acids across the inner mitochondria1 membrane. During the neonatal period the oxidation of fatty acids to produce energy is of grea importance and less than optimal carnitine intake may have a detrimental effect on growth and development.
Supported by NIH grant no. HD04946. Plasma arginine vasopressin (pAVP) release was measured befor< and during fet;rl hemorrhage (H) and 3 hours after fetal blood re placement ( T ) in 11 chronic fetal lamb preparations (103-138 day! gestation). During H there were significant decreases (p<0.05) i l fetal hematocrit (34.7t2.5 to 27+1.5%), arterial blood pressure (RP)(58.1?2.5 to 52.2'2.5 mmHg) and fetal pH (7.38f0.01 to 7.35i 0.01). but no changes were seen in arterial blood gases (PC02 -PO?), plasma electrolvtes (Na+, K t , C1-) nor osmolality. After T all values returned to baseline levels. Fetal pAVP was measured at various levels of H until 230% of the total feto-placental blood volume (T-FPV) was removed. Fetal pAVP increased significantly (p<O.01) in all fetuses from mean basal values of 0.73' 0.21 to mean peak values of 34.9i10.04 u~/ml. pAVP was returned to baseline values (1.77t0.67 uU/ml) 3 hours after T. No change in maternal pAVP was seen during H. When fetal pAVP was plotted against the percent of T-FPV removed, the correlation coefficien was 0.65; however, when the log of fetal pAVP was plotted agains the percent of T-FPV removed, a correlation coefficient of 0.82 was observed. A multiple regression analysis showed that the decrease in f c , t l l P,P w . ,~ n,,t th~. p r i i ,~. i r y factor explaining the increase in pAVP during T-FPV depletion. These data show that H is n potent stimulus for fetal pAVP release and suggest that this release is an exponential function of the degree to which T-FPV
I
The transport of alpha-aminoisobutyric acii and alpha-methyl D-glucoside by isolated renal tubules from Soraeue-Dawlev rats 1
at different scages of development follows a separate age-depend ent pattern for each substrate. The effects of 6 mM maleic acid on transport processes differ for amino acids and sugars and become manifest at distinct points during development. Maximum inhibition by maleic acid occurs at a time subsequent to complete maturation of these transport systems. In an effort to explain these transport phenomena, the uptake and metabolism of 14c-labelled maleic acid by the newborn and adult renal tubule was studied, showing significant binding by the tubule membrane penetration of the cell by diffusion, and no conversion to I4co2
Maleic acid has no demonstrable effect on the membrane-associate enzymes which are thought to play a role in the transport of small molecules. Though the mechanisms by which maleic acid inhibits the t r a port of sugars and amino acids in the adult rat tubule remains unexplained, it is clear that its effects are age-related and in dependent of the maturation of these transport systems. This observation is consistent with the delayed appearance of the Fanconi syndrome seen in human cystinosis and suggests that the progressive tubular dysfunction in this syndrome and in the maleic acid model is secondary to genetically directed intracell ular metabolic changes expressed during development. 
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